Ultragenyx Pharmaceutical Company

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

Investors

Founded Date: 2010
Employee Number: 501-1000
Funding Status: IPO
Technology: Immunotherapy
Industry: PharmTech
Headquarters: Novato, California, United States
Estimated Revenue: $10M to $50M
Register and Claim Ownership